title: Danaparoid in the prevention of ischemic stroke in paroxysmal nocturnal hemoglobinuria.
authors: Cerebrovascular Unit, Hôpital P. Wertheimer, Lyon, France.
authors: J
authors: J
authors: Zyss
authors: S
authors: S
authors: Cakmak
authors: L
authors: L
authors: Derex
authors: M
authors: M
authors: Michallet
authors: N
authors: N
authors: Nighoghossian
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications / Q000188:drug therapy*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D020762:Infarction, Posterior Cerebral Artery / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006497:Heparan Sulfate; C035838:danaparoid